Literature DB >> 3804938

Specificity of anti-polynucleotide monoclonal antibodies from human-human hybridomas.

S Hashizume, H Murakami, M Kamei, S Hirose, T Shirai, K Yamada, H Omura.   

Abstract

Nine human-human hybridoma clones, secreting monoclonal antibodies reactive with nucleic acids, were generated by fusing with lymphocytes of lung cancer or systemic lupus erythematosus patients. These hybridoma antibodies were classified into 5 types, in terms of reactivities with DNA, RNA, various synthetic nucleic acids and cardiolipin. Hybridoma clone SU-1 secreted antibody reacting with dsDNA, ssDNA and RNA (type I). Clone HL-321 did not react with these, but with poly (dT), poly (I) and poly (G) (type II). Clone HL-349 was reactive with almost all nucleic acids tested and also with cardiolipin (type III). Clones HF-4, HF-7, HB-7 and HL-259 reacted with ssDNA, poly (A), poly (G) and cardiolipin, but not with RNA (type IV). HB-5 and SH-9 antibodies were reactive only with poly (dT) (type V).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3804938     DOI: 10.1007/bf02623493

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  13 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Hybridoma autoantibodies to DNA.

Authors:  C Andrzejewski; B D Stollar; T M Lalor; R S Schwartz
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

3.  Specificity of mouse hybridoma antibodies to DNA.

Authors:  T Koike; R Nagasawa; N Nagata; T Shirai
Journal:  Immunol Lett       Date:  1982-02       Impact factor: 3.685

4.  Characterization of mouse and human monoclonal antibodies cross-reactive with SLE serum antibodies to guanosine.

Authors:  R H Weisbart; G Chan; A Kacena; R E Saxton
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

5.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

6.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

7.  Production of human hybridomas secreting antibodies to measles virus.

Authors:  C M Croce; A Linnenbach; W Hall; Z Steplewski; H Koprowski
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

8.  Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.

Authors:  L Olsson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.

Authors:  J Rauch; H Massicotte; H Tannenbaum
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

10.  Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.

Authors:  D Koffler; R Carr; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  8 in total

1.  Altered reactivity of immunoglobulin produced by human-human hybridoma cells transfected by pSV2-neo gene.

Authors:  H Tachibana; K Akiyama; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

2.  Increased antigen binding strengths of hybrid antibodies produced by human hybrid hybridomas.

Authors:  H Tachibana; S Shirahata; H Kawahara; H Murakami
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

Review 3.  Physiological enhancement of immunoglobulin production of hybridomas in serum-free media.

Authors:  H Murakami; K Yamada; S Shirahata; A Enomoto; S Kaminogawa
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

4.  Purification and characterization of lymphocytic clonal growth factor (LCGF) derived from human-human hybridoma SH-76 cells.

Authors:  M Miyata; H Murakami; S Hashizume; K Yamada; H Omura
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

5.  Characterization and applications of lymphocytic clonal growth factor in human plasma.

Authors:  M Miyata; S Hashizume; H Murakami; K Yamada; H Omura
Journal:  Cytotechnology       Date:  1988-07       Impact factor: 2.058

6.  Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions.

Authors:  K Yamada; I Ikeda; T Sugahara; S Hashizume; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

7.  A new human fusion partner, HK-128, for making human-human hybridomas producing monoclonal IgG antibodies.

Authors:  H Kawahara; K Yamada; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-09       Impact factor: 2.058

Review 8.  Hybridoma technology: new developments of practical interest.

Authors:  S R Samoilovich; C B Dugan; A J Macario
Journal:  J Immunol Methods       Date:  1987-08-03       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.